Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis

Hevir N, Neli Hevir, N Hevir, Vouk K, K Vouk, Katja Vouk, J Sinkovec, Sinkovec J, Jasna Šinkovec, Ribič-Pucelj M, Martina Ribič-Pucelj, M Ribič-Pucelj, Rižner TL, Tea Lanišnik Rižner, T Lanišnik Rižner
Chemico-biological interactions · 2011 · vol. 191(1-3) , pp. 217–226 · doi:10.1016/j.cbi.2011.01.003 · PMID:21232532 · W2098917345
article OA: closed CC0 ⤵ 16 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated how aldo-keto reductases AKR1C1, AKR1C2, and AKR1C3 might influence progesterone metabolism within ovarian endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a very common disease that is characterized by increased formation of estradiol and disturbed progesterone action. This latter is usually explained by a lack of progesterone receptor B (PR-B) expression, while the role of pre-receptor metabolism of progesterone is not yet fully understood. In normal endometrium, progesterone is metabolized by reductive 20α-hydroxysteroid dehydrogenases (20α-HSDs), 3α/β-HSDs and 5α/β-reductases. The aldo-keto reductases 1C1 and 1C3 (AKR1C1 and AKR1C3) are the major reductive 20α-HSDs, while the oxidative reaction is catalyzed by 17β-HSD type 2 (HSD17B2). Also, 3α-HSD and 3β-HSD activities have been associated with the AKR1C isozymes. Additionally, 5α-reductase types 1 and 2 (SRD5A1, SRD5A2) and 5β-reductase (AKR1D1) are responsible for the formation of 5α- and 5β-reduced pregnanes. In this study, we examined the expression of PR-AB and the progesterone metabolizing enzymes in 31 specimens of ovarian endometriosis and 28 specimens of normal endometrium. Real-time PCR analysis revealed significantly decreased mRNA levels of PR-AB, HSD17B2 and SRD5A2, significantly increased mRNA levels of AKR1C1, AKR1C2, AKR1C3 and SRD5A1, and negligible mRNA levels of AKR1D1. Immunohistochemistry staining of endometriotic tissue compared to control endometrium showed significantly lower PR-B levels in epithelial cells and no significant differences in stromal cells, there were no significant differences in the expression of AKR1C3 and significantly higher AKR1C2 levels were seen only in stromal cells. Our expression analysis data at the mRNA level and partially at the cellular level thus suggest enhanced metabolism of progesterone by SRD5A1 and the 20α-HSD and 3α/β-HSD activities of AKR1C1, AKR1C2 and AKR1C3.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Hydroxysteroid Dehydrogenases Hydroxysteroid Dehydrogenases Progesterone 20-Hydroxysteroid Dehydrogenases 20-Hydroxysteroid Dehydrogenases 20-Hydroxysteroid Dehydrogenases 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) 3-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Oxo-5-alpha-Steroid 4-Dehydrogenase 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Adult Aldo-Keto Reductase Family 1 Member C3 Down-Regulation Endometriosis Endometriosis Endometriosis Estradiol Dehydrogenases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (61)

Cited by (16)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:16:54.825375+00:00
unpaywall
last seen: 2026-07-26T06:48:27.953686+00:00
License: CC0 · commercial use OK